Abstract:Abstract Cyclin-dependent protein kinases (CDKs) regulate the eukaryotic cell cycle progression. Dysregulated cell cycle leading to unscheduled cell proliferation is a characteristic of many cancer subtypes. Since some tumor cells require specific interphase CDKs for proliferation, understanding CDKs activation mechanisms and their differential recognition of cognate cyclins and substrate proteins are essential for developing selective CDK inhibitors for cancer treatments. To date, while the crystal structure of the active CDK2 in complex with cyclin-E is available, no crystal structure for active CDK4 with its cognate cyclin-D is resolved. Here, we model the CDK4/cyclin-D complex as well as CDK2 in complex with cyclin-E to study the conformational dynamics and activation processes of G1 and G1/S phases CDKs, respectively. Extensive molecular dynamics (MD) simulations were performed for both CDK complexes with the kinases in different transition states to resolve the differences in their allosteric regulations at the atomic level. We illustrate that the inactive CDK4 in complex with cyclin-D is in the intermediate state on its pathway to activation in contrast to the fully active CDK2 in complex with cyclin-E, suggesting its activation mechanism is distinct from that of CDK2. This suggests that additional steps such as ATP binding, extension of the activation loop (A-loop), rotation of αC-helix towards “IN” conformation, phosphorylation of A-loop, and substrate binding are required for CDK4. CDK2 interacts with cyclin-E through a large interfacial area (or interface) that stabilizes the protein-protein interaction, while CDK4 has a smaller interfacial area (or interface) in the interaction with cyclin-D. Our simulations affirm experimental data on the current understanding of activation mechanisms of CDK2 and CDK4 and reveal additional atomistical characteristics of their dynamics and activations. Our works report the complete activation mechanisms of CDK2/4, providing insights into the inhibition of these complexes at an atomic level, and are useful for identifying potential targets for drug discovery in oncology. Citation Format: Wengang Zhang, Yonglan Liu, Mingzhen Zhang, Hyunbum Jang, Ruth Nussinov. Deciphering the activation mechanism of CDK4/cyclin-D complex that differs from the CDK2/cyclin-E complex [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 872.

A comparative study of the cryo-EM structures of and human anaphase-promoting complex/cyclosome (APC/C)

A comparative study of the cryo-EM structures of Saccharomyces cerevisiae and human anaphase-promoting complex/cyclosome (APC/C)

New structural features of the APC/C revealed by high resolution cryo-EM structures of apo-APC/C and the APC/C CDH1:EMI1 complex

Cryo-EM of Mitotic Checkpoint Complex-Bound APC/C Reveals Reciprocal and Conformational Regulation of Ubiquitin Ligation

Structural Basis for Chk1 Inhibition by UCN-01 and Its Analogs

Insights into Apc/C: from Cellular Function to Diseases and Therapeutics

The Function of Apc/C-Cdh1 in Cell Cycle and Beyond

Ciliary Central Apparatus Structure Reveals Mechanisms of Microtubule Patterning

Cryo-EM structure of the CDK2-cyclin A-CDC25A complex

Functional Characterization of Anaphase Promoting Complex/Cyclosome (APC/C) E3 Ubiquitin Ligases in Tumorigenesis

The function of APC/C<sup>Cdh1 </sup>in cell cycle and beyond

Structural Analysis of Human Cdc20 Supports Multisite Degron Recognition by APC/C

Review the Function of APC/C Cdh1 in Cell Cycle and Beyond

Differential expression, localization and activity of two alternatively spliced isoforms of human APC regulator CDH1.

Modeling potent pathways for APC/C inhibition: pivotal roles for MCC and BubR1

Synergistic blockade of mitotic exit by two chemical inhibitors of the APC/C.

Differential Expression, Localization And Activity Of Two Alternatively Spliced Isoforms Of Human Apc Regulator Cdh1

Abstract 872: Deciphering the Activation Mechanism of CDK4/cyclin-D Complex That Differs from the CDK2/cyclin-E Complex

Specificity of the anaphase-promoting complex: A single-molecule study

The C-terminal disordered loop domain of Apc8 unlocks APC/C mitotic activation

The Structure and Function of SCF and APC/C